PA
RVNC

Procyon Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Procyon Advisors’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,900
Closed -$46K – 1100
2020
Q2 		$46K Buy
1,900
+200
+12% +$4.84K 0.02% 392
2020
Q1 		$25K Hold
1,700
– – 0.02% 442
2019
Q4 		$28K Buy
+1,700
New +$28K 0.02% 442